EP1620565A4 - Method for detection and characterization of pre-malignant transformation - Google Patents

Method for detection and characterization of pre-malignant transformation

Info

Publication number
EP1620565A4
EP1620565A4 EP04750949A EP04750949A EP1620565A4 EP 1620565 A4 EP1620565 A4 EP 1620565A4 EP 04750949 A EP04750949 A EP 04750949A EP 04750949 A EP04750949 A EP 04750949A EP 1620565 A4 EP1620565 A4 EP 1620565A4
Authority
EP
European Patent Office
Prior art keywords
characterization
detection
malignant transformation
malignant
transformation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP04750949A
Other languages
German (de)
French (fr)
Other versions
EP1620565A2 (en
Inventor
Sancy Leachman
Christos Hatzis
Nandan Padukone
Harold Erickson
Patricia Porter-Gill
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Utah Research Foundation UURF
Nuvera Biosciences Inc
Original Assignee
University of Utah Research Foundation UURF
Nuvera Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Utah Research Foundation UURF, Nuvera Biosciences Inc filed Critical University of Utah Research Foundation UURF
Publication of EP1620565A2 publication Critical patent/EP1620565A2/en
Publication of EP1620565A4 publication Critical patent/EP1620565A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/5743—Specifically defined cancers of skin, e.g. melanoma
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EP04750949A 2003-04-29 2004-04-29 Method for detection and characterization of pre-malignant transformation Withdrawn EP1620565A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46606103P 2003-04-29 2003-04-29
PCT/US2004/013318 WO2004096020A2 (en) 2003-04-29 2004-04-29 Method for detection and characterization of pre-malignant transformation

Publications (2)

Publication Number Publication Date
EP1620565A2 EP1620565A2 (en) 2006-02-01
EP1620565A4 true EP1620565A4 (en) 2008-04-02

Family

ID=33418336

Family Applications (1)

Application Number Title Priority Date Filing Date
EP04750949A Withdrawn EP1620565A4 (en) 2003-04-29 2004-04-29 Method for detection and characterization of pre-malignant transformation

Country Status (4)

Country Link
US (1) US20070105102A1 (en)
EP (1) EP1620565A4 (en)
CA (1) CA2524064A1 (en)
WO (1) WO2004096020A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1620565A4 (en) * 2003-04-29 2008-04-02 Univ Utah Res Found Method for detection and characterization of pre-malignant transformation
CA2706313A1 (en) 2007-11-19 2009-05-28 Bionovo, Inc. Methods of detecting and treatment of cancers using scuttelaria barbata extract

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002003979A2 (en) * 2000-07-12 2002-01-17 Board Of Regents, The University Of Texas System Combination of 2-methoxyestradiol and an agent that increases intracellular superoxide anion

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756332A (en) * 1996-12-26 1998-05-26 Incyte Pharmaceuticals, Inc. Guanosine monophosphate reductase
EP1620565A4 (en) * 2003-04-29 2008-04-02 Univ Utah Res Found Method for detection and characterization of pre-malignant transformation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002003979A2 (en) * 2000-07-12 2002-01-17 Board Of Regents, The University Of Texas System Combination of 2-methoxyestradiol and an agent that increases intracellular superoxide anion

Also Published As

Publication number Publication date
WO2004096020A2 (en) 2004-11-11
WO2004096020A3 (en) 2005-07-07
CA2524064A1 (en) 2004-11-11
EP1620565A2 (en) 2006-02-01
US20070105102A1 (en) 2007-05-10

Similar Documents

Publication Publication Date Title
GB0207944D0 (en) Method of detection
EP1929432A4 (en) Rf point of purchase apparatus and method of using same
GB2418693B (en) Method and apparatus for formation testing
EP1680650A4 (en) System and method for spectral analysis
HK1081236A1 (en) Method of estimating elimination of microorganisms and apparatus for estimating elimination of microorganisms
EP1925108A4 (en) System and method for detection of primary spectrum users
IL173845A0 (en) Method of detecting concealed objects
IL160534A0 (en) Apparatus and method for pulse detection and characterization
AU2003271637A8 (en) Analytical chip for detection of 16s-rrna from clinically relevant bacteria and analytical method based thereon
IL175657A0 (en) Derivatives of dihydronepetalactone and method for preparation
GB0412654D0 (en) Method of detection
EP1709461A4 (en) Object detection method and apparatus
GB0409867D0 (en) Misfire detection system and method of median filtering
IL158097A (en) Method and system for detection of objects
GB0303936D0 (en) Method of testing
GB0300507D0 (en) Apparatus for and method of ground fault detection
EP1620565A4 (en) Method for detection and characterization of pre-malignant transformation
AU2003263271A8 (en) Method capable of being automated for detection of prpless thanspgreater thanresless than/spgreater than and uses thereof
KR100527793B1 (en) Probe for detecting hanwoo and method of detecting hanwoo using the same
GB0413208D0 (en) Detection method and apparatus
GB0312561D0 (en) Apparatus and method of using same
EP1618661A4 (en) Method and apparatus for conversionless direct detection
AU2003288762A1 (en) Method and apparatus of hemorheometer
GB2400436B (en) Real-time method for the detection and characterization of scale
GB2399951B (en) Apparatus and method for signal transformation

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20051121

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL HR LT LV MK

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NUVERA BIOSCIENCES, INC.

Owner name: THE UNIVERSITY OF UTAH RESEARCH FOUNDATION

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20080305

17Q First examination report despatched

Effective date: 20080827

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20090108